|
⚲
|
| Keyboard |
| Wolf Myles
✚
|
|
|---|---|
| CIK # | 0001808317 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001808317] | |
| 4 | [0001808317] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Wolf Myles | |
| Akebia Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
|
2025-06-10 | Grant | 53,600 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2025-06-10 | Grant | 35,700 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2024-06-06 | Grant | 30,000 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
|
2024-06-06 | Grant | 45,000 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2023-06-06 | Grant | 30,000 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
|
2023-06-06 | Grant | 45,000 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
|
2022-06-08 | Grant | 20,100 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2022-06-08 | Grant | 13,700 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Common Stock
|
2021-06-02 | Grant | 13,700 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
|
2021-06-02 | Grant | 20,100 | $0.00 | |
|
Akebia Therapeutics Inc AKBA
Stock Option (Right to buy) · derivative
|
2020-04-06 | Grant | 80,200 | $0.00 |